Skip to main content

tolinapant

Generic: Tolinapant

tolinapant: 2 clinical trials tracked.

tolinapant evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about tolinapant, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 0 study sponsors

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (2)

A Phase 1-2, Open-Label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Activity of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma

NCT05403450Registry updated 2026-07-09·Phase 1
Terminated

Primary endpoint: Phase 1: Number of Participants With Treatment-Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and Dose Limiting Toxicities (DLTs)

InterventionalRandomizedopen33 enrolledStarted 2023-02Completion 2026-0746 sites · Australia, France, Italy, Poland…Taiho Oncology, Inc.

ASTEROID:A Phase I Trial of ASTX660 in Combination With Pembrolizumab in Patients With Solid Tumours: Utilizing Triple IAP Blockade as a Strategy to Maximize Immunogenic Cell Death and the Generation of an Efficient Adaptive Immune Response

NCT05082259Registry updated 2026-06-25·Phase 1
Active, not recruiting

Primary endpoint: Determination of MTD and RP2D

Interventionalopen61 targetStarted 2022-03Completion 2026-123 sites · United KingdomInstitute of Cancer Research, United Kingdom